Development of GD2-Specific Immunoliposomes for Immunotherapy of Neuroblastoma

被引：1
|
作者：
Huang, Wei [1 ]
Liu, Daofeng [1 ]
Guo, Linjie [1 ]
Marinova, Ekaterina [1 ]
Heczey, Andras [1 ]
Metelitsa, Leonid [1 ]
机构：
[1] Baylor Coll Medcine, Houston, TX USA
来源：
MOLECULAR THERAPY | 2016年 / 24卷
关键词：
D O I：
10.1016/S1525-0016(16)33205-1
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
396
引用
收藏
页码：S157 / S157
页数：1
相关论文
共 50 条
  • [1] Development of GD2-Specific Immunoliposomes for Immunotherapy of Neuroblastoma
    Huang, Wei
    Liu, Daofeng
    Guo, Linjie
    Dotti, Gianpietro
    Metelitsa, Leonid S.
    MOLECULAR THERAPY, 2015, 23 : S163 - S163
  • [2] T-CELLS GRAFTED WITH GD2-SPECIFIC ANTITUMOUR ACTIVITY: DEVELOPMENT OF IMMUNOTHERAPY FOR NEUROBLASTOMA
    Straathof, Karin
    Kokalaki, Evangelia
    Philip, Brian
    Himoudi, Nourredine
    Pule, Martin
    Anderson, John
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1006 - 1006
  • [3] Translational immunoPET imaging using a radiolabeled GD2-specific antibody in neuroblastoma
    Schmitt, Julia
    Schwenck, Johannes
    Maurer, Andreas
    Przybille, Mirko
    Sonanini, Dominik
    Reischl, Gerald
    Wehrmueller, Joeri E.
    Quintanilla-Martinez, Leticia
    Gillies, Stephen D.
    Krueger, Marcel A.
    Schaefer, Juergen F.
    la Fougere, Christian
    Handgretinger, Rupert
    Pichler, Bernd J.
    THERANOSTICS, 2022, 12 (12): : 5615 - 5630
  • [4] Donor-derived GD2-specific CAR T cells in relapsed or refractory neuroblastoma
    Quintarelli, Concetta
    Del Bufalo, Francesca
    De Ioris, Maria Antonietta
    Guercio, Marika
    Algeri, Mattia
    Pagliara, Daria
    Silvestris, Domenico Alessandro
    Di Nardo, Matteo
    Sinibaldi, Matilde
    Di Cecca, Stefano
    Iaffaldano, Laura
    Manni, Simona
    Fustaino, Valentina
    Garganese, Maria Carmen
    Colafati, Giovanna Stefania
    Bertaina, Valentina
    Becilli, Marco
    Mastronuzzi, Angela
    Fabozzi, Francesco
    Gunetti, Monica
    Iacovelli, Stefano
    Bugianesi, Rossana
    Macchia, Stefania
    Li Pira, Giuseppina
    Cefalo, Maria Giuseppina
    Leone, Giovanna
    Del Baldo, Giada
    De Angelis, Biagio
    Locatelli, Franco
    NATURE MEDICINE, 2025, : 849 - 860
  • [5] Immunotherapy of Metastatic Melanoma Using Genetically Engineered GD2-Specific T cells
    Yvon, Eric
    Del Vecchio, Michele
    Savoldo, Barbara
    Hoyos, Valentina
    Dutour, Aurelie
    Anichini, Andrea
    Dotti, Gianpietro
    Brenner, Malcolm K.
    CLINICAL CANCER RESEARCH, 2009, 15 (18) : 5852 - 5860
  • [6] Immunotherapy of Metastatic Melanoma Using Genetically Engineered GD2-Specific T Cells
    Yvon, Eric S.
    Savoldo, Barbara
    Hoyos, Valentina
    Dutour, Aurelie
    Bollard, Catherine M.
    Dotti, Gianpietro
    Brenner, Malcolm K.
    MOLECULAR THERAPY, 2009, 17 : S26 - S26
  • [7] Anti-GD2 immunoliposomes loaded with oxamate for neuroblastoma
    William S. Panosyan
    Daniel E. Panosyan
    Jan Koster
    Eduard H. Panosyan
    Pediatric Research, 2023, 94 : 458 - 461
  • [8] Combination Therapy of GD2-Specific CAR-T Cells with Tyrosine Kinase Inhibitors for Neuroblastoma
    Tomida, Akimasa
    Yagyu, Shigeki
    Yamashima, Kumiko
    Kubo, Hiroshi
    Iehara, Tomoko
    Nakamura, Kayoko
    Nakazawa, Yozo
    Hosoi, Hajime
    MOLECULAR THERAPY, 2020, 28 (04) : 146 - 146
  • [9] Vaccination with anti-idiotype antibody ganglidiomab mediates a GD2-specific anti-neuroblastoma immune response
    Holger N. Lode
    Manuela Schmidt
    Diana Seidel
    Nicole Huebener
    Diana Brackrock
    Matthias Bleeke
    Daniel Reker
    Sven Brandt
    Hans-Peter Mueller
    Christiane Helm
    Nikolai Siebert
    Cancer Immunology, Immunotherapy, 2013, 62 : 999 - 1010
  • [10] Anti-GD2 immunotherapy for neuroblastoma
    Sait, Sameer
    Modak, Shakeel
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (10) : 889 - 904
12345